 | • レポートコード：QYR2104Z3248 • 出版社/出版日：QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、90ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療 |
| Single User | ￥546,000 (USD3,900) | ▷ お問い合わせ |
| Multi User/Five User | ￥819,000 (USD5,850) | ▷ お問い合わせ |
| Enterprise License（同一法人内共有可） | ￥1,092,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の本調査資料では、In-Vitro毒性試験・毒性試験のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（細胞培養技術、ハイスループット技術、分子イメージング技術、オミクス技術）、用途別市場規模（製薬業、化学工業、食品業、その他）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・In-Vitro毒性試験・毒性試験の市場動向 ・企業の競争状況、市場シェア ・In-Vitro毒性試験・毒性試験の種類別市場規模（細胞培養技術、ハイスループット技術、分子イメージング技術、オミクス技術） ・In-Vitro毒性試験・毒性試験の用途別市場規模（製薬業、化学工業、食品業、その他） ・In-Vitro毒性試験・毒性試験の北米市場規模2016-2027（アメリカ、カナダ） ・In-Vitro毒性試験・毒性試験のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・In-Vitro毒性試験・毒性試験のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・In-Vitro毒性試験・毒性試験の中南米市場規模2016-2027（メキシコ、ブラジル） ・In-Vitro毒性試験・毒性試験の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（GE Healthcare、Thermo Fisher Scientific、Bio-Rad Laboratories、Agilent Technologies、Cyprotex、Covance、Bioreliance、Catalent、Charles River Laboratories International、Alere、Eurofins Scientific、Life Technologies Corporation、Quest Diagnostics） ・結論 |
Market Analysis and Insights: Global In-Vitro Toxicology and Toxicity Testing Market
The global In-Vitro Toxicology and Toxicity Testing market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global In-Vitro Toxicology and Toxicity Testing market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global In-Vitro Toxicology and Toxicity Testing market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global In-Vitro Toxicology and Toxicity Testing market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global In-Vitro Toxicology and Toxicity Testing market.
Global In-Vitro Toxicology and Toxicity Testing Scope and Market Size
In-Vitro Toxicology and Toxicity Testing market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global In-Vitro Toxicology and Toxicity Testing market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
Cell Culture Technology
High Throughput Technologies
Molecular Imaging Technologies
Omics Technologies
Segment by Application
Pharmaceutical Industry
Chemical Industry
Food Industry
Other
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
GE Healthcare
Thermo Fisher Scientific
Bio-Rad Laboratories
Agilent Technologies
Cyprotex
Covance
Bioreliance
Catalent
Charles River Laboratories International
Alere
Eurofins Scientific
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global In-Vitro Toxicology and Toxicity Testing Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Cell Culture Technology
1.2.3 High Throughput Technologies
1.2.4 Molecular Imaging Technologies
1.2.5 Omics Technologies
1.3 Market by Application
1.3.1 Global In-Vitro Toxicology and Toxicity Testing Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Pharmaceutical Industry
1.3.3 Chemical Industry
1.3.4 Food Industry
1.3.5 Other
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global In-Vitro Toxicology and Toxicity Testing Market Perspective (2016-2027)
2.2 In-Vitro Toxicology and Toxicity Testing Growth Trends by Regions
2.2.1 In-Vitro Toxicology and Toxicity Testing Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 In-Vitro Toxicology and Toxicity Testing Historic Market Share by Regions (2016-2021)
2.2.3 In-Vitro Toxicology and Toxicity Testing Forecasted Market Size by Regions (2022-2027)
2.3 In-Vitro Toxicology and Toxicity Testing Industry Dynamic
2.3.1 In-Vitro Toxicology and Toxicity Testing Market Trends
2.3.2 In-Vitro Toxicology and Toxicity Testing Market Drivers
2.3.3 In-Vitro Toxicology and Toxicity Testing Market Challenges
2.3.4 In-Vitro Toxicology and Toxicity Testing Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top In-Vitro Toxicology and Toxicity Testing Players by Revenue
3.1.1 Global Top In-Vitro Toxicology and Toxicity Testing Players by Revenue (2016-2021)
3.1.2 Global In-Vitro Toxicology and Toxicity Testing Revenue Market Share by Players (2016-2021)
3.2 Global In-Vitro Toxicology and Toxicity Testing Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by In-Vitro Toxicology and Toxicity Testing Revenue
3.4 Global In-Vitro Toxicology and Toxicity Testing Market Concentration Ratio
3.4.1 Global In-Vitro Toxicology and Toxicity Testing Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by In-Vitro Toxicology and Toxicity Testing Revenue in 2020
3.5 In-Vitro Toxicology and Toxicity Testing Key Players Head office and Area Served
3.6 Key Players In-Vitro Toxicology and Toxicity Testing Product Solution and Service
3.7 Date of Enter into In-Vitro Toxicology and Toxicity Testing Market
3.8 Mergers & Acquisitions, Expansion Plans
4 In-Vitro Toxicology and Toxicity Testing Breakdown Data by Type
4.1 Global In-Vitro Toxicology and Toxicity Testing Historic Market Size by Type (2016-2021)
4.2 Global In-Vitro Toxicology and Toxicity Testing Forecasted Market Size by Type (2022-2027)
5 In-Vitro Toxicology and Toxicity Testing Breakdown Data by Application
5.1 Global In-Vitro Toxicology and Toxicity Testing Historic Market Size by Application (2016-2021)
5.2 Global In-Vitro Toxicology and Toxicity Testing Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America In-Vitro Toxicology and Toxicity Testing Market Size (2016-2027)
6.2 North America In-Vitro Toxicology and Toxicity Testing Market Size by Type
6.2.1 North America In-Vitro Toxicology and Toxicity Testing Market Size by Type (2016-2021)
6.2.2 North America In-Vitro Toxicology and Toxicity Testing Market Size by Type (2022-2027)
6.2.3 North America In-Vitro Toxicology and Toxicity Testing Market Size by Type (2016-2027)
6.3 North America In-Vitro Toxicology and Toxicity Testing Market Size by Application
6.3.1 North America In-Vitro Toxicology and Toxicity Testing Market Size by Application (2016-2021)
6.3.2 North America In-Vitro Toxicology and Toxicity Testing Market Size by Application (2022-2027)
6.3.3 North America In-Vitro Toxicology and Toxicity Testing Market Size by Application (2016-2027)
6.4 North America In-Vitro Toxicology and Toxicity Testing Market Size by Country
6.4.1 North America In-Vitro Toxicology and Toxicity Testing Market Size by Country (2016-2021)
6.4.2 North America In-Vitro Toxicology and Toxicity Testing Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada
7 Europe
7.1 Europe In-Vitro Toxicology and Toxicity Testing Market Size (2016-2027)
7.2 Europe In-Vitro Toxicology and Toxicity Testing Market Size by Type
7.2.1 Europe In-Vitro Toxicology and Toxicity Testing Market Size by Type (2016-2021)
7.2.2 Europe In-Vitro Toxicology and Toxicity Testing Market Size by Type (2022-2027)
7.2.3 Europe In-Vitro Toxicology and Toxicity Testing Market Size by Type (2016-2027)
7.3 Europe In-Vitro Toxicology and Toxicity Testing Market Size by Application
7.3.1 Europe In-Vitro Toxicology and Toxicity Testing Market Size by Application (2016-2021)
7.3.2 Europe In-Vitro Toxicology and Toxicity Testing Market Size by Application (2022-2027)
7.3.3 Europe In-Vitro Toxicology and Toxicity Testing Market Size by Application (2016-2027)
7.4 Europe In-Vitro Toxicology and Toxicity Testing Market Size by Country
7.4.1 Europe In-Vitro Toxicology and Toxicity Testing Market Size by Country (2016-2021)
7.4.2 Europe In-Vitro Toxicology and Toxicity Testing Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific In-Vitro Toxicology and Toxicity Testing Market Size (2016-2027)
8.2 Asia-Pacific In-Vitro Toxicology and Toxicity Testing Market Size by Type
8.2.1 Asia-Pacific In-Vitro Toxicology and Toxicity Testing Market Size by Type (2016-2021)
8.2.2 Asia-Pacific In-Vitro Toxicology and Toxicity Testing Market Size by Type (2022-2027)
8.2.3 Asia-Pacific In-Vitro Toxicology and Toxicity Testing Market Size by Type (2016-2027)
8.3 Asia-Pacific In-Vitro Toxicology and Toxicity Testing Market Size by Application
8.3.1 Asia-Pacific In-Vitro Toxicology and Toxicity Testing Market Size by Application (2016-2021)
8.3.2 Asia-Pacific In-Vitro Toxicology and Toxicity Testing Market Size by Application (2022-2027)
8.3.3 Asia-Pacific In-Vitro Toxicology and Toxicity Testing Market Size by Application (2016-2027)
8.4 Asia-Pacific In-Vitro Toxicology and Toxicity Testing Market Size by Region
8.4.1 Asia-Pacific In-Vitro Toxicology and Toxicity Testing Market Size by Region (2016-2021)
8.4.2 Asia-Pacific In-Vitro Toxicology and Toxicity Testing Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America In-Vitro Toxicology and Toxicity Testing Market Size (2016-2027)
9.2 Latin America In-Vitro Toxicology and Toxicity Testing Market Size by Type
9.2.1 Latin America In-Vitro Toxicology and Toxicity Testing Market Size by Type (2016-2021)
9.2.2 Latin America In-Vitro Toxicology and Toxicity Testing Market Size by Type (2022-2027)
9.2.3 Latin America In-Vitro Toxicology and Toxicity Testing Market Size by Type (2016-2027)
9.3 Latin America In-Vitro Toxicology and Toxicity Testing Market Size by Application
9.3.1 Latin America In-Vitro Toxicology and Toxicity Testing Market Size by Application (2016-2021)
9.3.2 Latin America In-Vitro Toxicology and Toxicity Testing Market Size by Application (2022-2027)
9.3.3 Latin America In-Vitro Toxicology and Toxicity Testing Market Size by Application (2016-2027)
9.4 Latin America In-Vitro Toxicology and Toxicity Testing Market Size by Country
9.4.1 Latin America In-Vitro Toxicology and Toxicity Testing Market Size by Country (2016-2021)
9.4.2 Latin America In-Vitro Toxicology and Toxicity Testing Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa In-Vitro Toxicology and Toxicity Testing Market Size (2016-2027)
10.2 Middle East & Africa In-Vitro Toxicology and Toxicity Testing Market Size by Type
10.2.1 Middle East & Africa In-Vitro Toxicology and Toxicity Testing Market Size by Type (2016-2021)
10.2.2 Middle East & Africa In-Vitro Toxicology and Toxicity Testing Market Size by Type (2022-2027)
10.2.3 Middle East & Africa In-Vitro Toxicology and Toxicity Testing Market Size by Type (2016-2027)
10.3 Middle East & Africa In-Vitro Toxicology and Toxicity Testing Market Size by Application
10.3.1 Middle East & Africa In-Vitro Toxicology and Toxicity Testing Market Size by Application (2016-2021)
10.3.2 Middle East & Africa In-Vitro Toxicology and Toxicity Testing Market Size by Application (2022-2027)
10.3.3 Middle East & Africa In-Vitro Toxicology and Toxicity Testing Market Size by Application (2016-2027)
10.4 Middle East & Africa In-Vitro Toxicology and Toxicity Testing Market Size by Country
10.4.1 Middle East & Africa In-Vitro Toxicology and Toxicity Testing Market Size by Country (2016-2021)
10.4.2 Middle East & Africa In-Vitro Toxicology and Toxicity Testing Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 GE Healthcare
11.1.1 GE Healthcare Company Details
11.1.2 GE Healthcare Business Overview
11.1.3 GE Healthcare In-Vitro Toxicology and Toxicity Testing Introduction
11.1.4 GE Healthcare Revenue in In-Vitro Toxicology and Toxicity Testing Business (2016-2021)
11.1.5 GE Healthcare Recent Development
11.2 Thermo Fisher Scientific
11.2.1 Thermo Fisher Scientific Company Details
11.2.2 Thermo Fisher Scientific Business Overview
11.2.3 Thermo Fisher Scientific In-Vitro Toxicology and Toxicity Testing Introduction
11.2.4 Thermo Fisher Scientific Revenue in In-Vitro Toxicology and Toxicity Testing Business (2016-2021)
11.2.5 Thermo Fisher Scientific Recent Development
11.3 Bio-Rad Laboratories
11.3.1 Bio-Rad Laboratories Company Details
11.3.2 Bio-Rad Laboratories Business Overview
11.3.3 Bio-Rad Laboratories In-Vitro Toxicology and Toxicity Testing Introduction
11.3.4 Bio-Rad Laboratories Revenue in In-Vitro Toxicology and Toxicity Testing Business (2016-2021)
11.3.5 Bio-Rad Laboratories Recent Development
11.4 Agilent Technologies
11.4.1 Agilent Technologies Company Details
11.4.2 Agilent Technologies Business Overview
11.4.3 Agilent Technologies In-Vitro Toxicology and Toxicity Testing Introduction
11.4.4 Agilent Technologies Revenue in In-Vitro Toxicology and Toxicity Testing Business (2016-2021)
11.4.5 Agilent Technologies Recent Development
11.5 Cyprotex
11.5.1 Cyprotex Company Details
11.5.2 Cyprotex Business Overview
11.5.3 Cyprotex In-Vitro Toxicology and Toxicity Testing Introduction
11.5.4 Cyprotex Revenue in In-Vitro Toxicology and Toxicity Testing Business (2016-2021)
11.5.5 Cyprotex Recent Development
11.6 Covance
11.6.1 Covance Company Details
11.6.2 Covance Business Overview
11.6.3 Covance In-Vitro Toxicology and Toxicity Testing Introduction
11.6.4 Covance Revenue in In-Vitro Toxicology and Toxicity Testing Business (2016-2021)
11.6.5 Covance Recent Development
11.7 Bioreliance
11.7.1 Bioreliance Company Details
11.7.2 Bioreliance Business Overview
11.7.3 Bioreliance In-Vitro Toxicology and Toxicity Testing Introduction
11.7.4 Bioreliance Revenue in In-Vitro Toxicology and Toxicity Testing Business (2016-2021)
11.7.5 Bioreliance Recent Development
11.8 Catalent
11.8.1 Catalent Company Details
11.8.2 Catalent Business Overview
11.8.3 Catalent In-Vitro Toxicology and Toxicity Testing Introduction
11.8.4 Catalent Revenue in In-Vitro Toxicology and Toxicity Testing Business (2016-2021)
11.8.5 Catalent Recent Development
11.9 Charles River Laboratories International
11.9.1 Charles River Laboratories International Company Details
11.9.2 Charles River Laboratories International Business Overview
11.9.3 Charles River Laboratories International In-Vitro Toxicology and Toxicity Testing Introduction
11.9.4 Charles River Laboratories International Revenue in In-Vitro Toxicology and Toxicity Testing Business (2016-2021)
11.9.5 Charles River Laboratories International Recent Development
11.10 Alere
11.10.1 Alere Company Details
11.10.2 Alere Business Overview
11.10.3 Alere In-Vitro Toxicology and Toxicity Testing Introduction
11.10.4 Alere Revenue in In-Vitro Toxicology and Toxicity Testing Business (2016-2021)
11.10.5 Alere Recent Development
11.11 Eurofins Scientific
11.11.1 Eurofins Scientific Company Details
11.11.2 Eurofins Scientific Business Overview
11.11.3 Eurofins Scientific In-Vitro Toxicology and Toxicity Testing Introduction
11.11.4 Eurofins Scientific Revenue in In-Vitro Toxicology and Toxicity Testing Business (2016-2021)
11.11.5 Eurofins Scientific Recent Development
11.12 Life Technologies Corporation
11.12.1 Life Technologies Corporation Company Details
11.12.2 Life Technologies Corporation Business Overview
11.12.3 Life Technologies Corporation In-Vitro Toxicology and Toxicity Testing Introduction
11.12.4 Life Technologies Corporation Revenue in In-Vitro Toxicology and Toxicity Testing Business (2016-2021)
11.12.5 Life Technologies Corporation Recent Development
11.13 Quest Diagnostics
11.13.1 Quest Diagnostics Company Details
11.13.2 Quest Diagnostics Business Overview
11.13.3 Quest Diagnostics In-Vitro Toxicology and Toxicity Testing Introduction
11.13.4 Quest Diagnostics Revenue in In-Vitro Toxicology and Toxicity Testing Business (2016-2021)
11.13.5 Quest Diagnostics Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global In-Vitro Toxicology and Toxicity Testing Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Cell Culture Technology
Table 3. Key Players of High Throughput Technologies
Table 4. Key Players of Molecular Imaging Technologies
Table 5. Key Players of Omics Technologies
Table 6. Global In-Vitro Toxicology and Toxicity Testing Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global In-Vitro Toxicology and Toxicity Testing Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global In-Vitro Toxicology and Toxicity Testing Market Size by Regions (2016-2021) & (US$ Million)
Table 9. Global In-Vitro Toxicology and Toxicity Testing Market Share by Regions (2016-2021)
Table 10. Global In-Vitro Toxicology and Toxicity Testing Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 11. Global In-Vitro Toxicology and Toxicity Testing Market Share by Regions (2022-2027)
Table 12. In-Vitro Toxicology and Toxicity Testing Market Trends
Table 13. In-Vitro Toxicology and Toxicity Testing Market Drivers
Table 14. In-Vitro Toxicology and Toxicity Testing Market Challenges
Table 15. In-Vitro Toxicology and Toxicity Testing Market Restraints
Table 16. Global In-Vitro Toxicology and Toxicity Testing Revenue by Players (2016-2021) & (US$ Million)
Table 17. Global In-Vitro Toxicology and Toxicity Testing Market Share by Players (2016-2021)
Table 18. Global Top In-Vitro Toxicology and Toxicity Testing Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in In-Vitro Toxicology and Toxicity Testing as of 2020)
Table 19. Ranking of Global Top In-Vitro Toxicology and Toxicity Testing Companies by Revenue (US$ Million) in 2020
Table 20. Global 5 Largest Players Market Share by In-Vitro Toxicology and Toxicity Testing Revenue (CR5 and HHI) & (2016-2021)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players In-Vitro Toxicology and Toxicity Testing Product Solution and Service
Table 23. Date of Enter into In-Vitro Toxicology and Toxicity Testing Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global In-Vitro Toxicology and Toxicity Testing Market Size by Type (2016-2021) (US$ Million)
Table 26. Global In-Vitro Toxicology and Toxicity Testing Revenue Market Share by Type (2016-2021)
Table 27. Global In-Vitro Toxicology and Toxicity Testing Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 28. Global In-Vitro Toxicology and Toxicity Testing Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 29. Global In-Vitro Toxicology and Toxicity Testing Market Size Share by Application (2016-2021) & (US$ Million)
Table 30. Global In-Vitro Toxicology and Toxicity Testing Revenue Market Share by Application (2016-2021)
Table 31. Global In-Vitro Toxicology and Toxicity Testing Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 32. Global In-Vitro Toxicology and Toxicity Testing Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 33. North America In-Vitro Toxicology and Toxicity Testing Market Size by Type (2016-2021) (US$ Million)
Table 34. North America In-Vitro Toxicology and Toxicity Testing Market Size by Type (2022-2027) & (US$ Million)
Table 35. North America In-Vitro Toxicology and Toxicity Testing Market Size by Application (2016-2021) (US$ Million)
Table 36. North America In-Vitro Toxicology and Toxicity Testing Market Size by Application (2022-2027) & (US$ Million)
Table 37. North America In-Vitro Toxicology and Toxicity Testing Market Size by Country (2016-2021) & (US$ Million)
Table 38. North America In-Vitro Toxicology and Toxicity Testing Market Size by Country (2022-2027) & (US$ Million)
Table 39. Europe In-Vitro Toxicology and Toxicity Testing Market Size by Type (2016-2021) (US$ Million)
Table 40. Europe In-Vitro Toxicology and Toxicity Testing Market Size by Type (2022-2027) & (US$ Million)
Table 41. Europe In-Vitro Toxicology and Toxicity Testing Market Size by Application (2016-2021) (US$ Million)
Table 42. Europe In-Vitro Toxicology and Toxicity Testing Market Size by Application (2022-2027) & (US$ Million)
Table 43. Europe In-Vitro Toxicology and Toxicity Testing Market Size by Country (2016-2021) & (US$ Million)
Table 44. Europe In-Vitro Toxicology and Toxicity Testing Market Size by Country (2022-2027) & (US$ Million)
Table 45. Asia-Pacific In-Vitro Toxicology and Toxicity Testing Market Size by Type (2016-2021) (US$ Million)
Table 46. Asia-Pacific In-Vitro Toxicology and Toxicity Testing Market Size by Type (2022-2027) & (US$ Million)
Table 47. Asia-Pacific In-Vitro Toxicology and Toxicity Testing Market Size by Application (2016-2021) (US$ Million)
Table 48. Asia-Pacific In-Vitro Toxicology and Toxicity Testing Market Size by Application (2022-2027) & (US$ Million)
Table 49. Asia-Pacific In-Vitro Toxicology and Toxicity Testing Market Size by Region (2016-2021) & (US$ Million)
Table 50. Asia-Pacific In-Vitro Toxicology and Toxicity Testing Market Size by Region (2022-2027) & (US$ Million)
Table 51. Latin America In-Vitro Toxicology and Toxicity Testing Market Size by Type (2016-2021) (US$ Million)
Table 52. Latin America In-Vitro Toxicology and Toxicity Testing Market Size by Type (2022-2027) & (US$ Million)
Table 53. Latin America In-Vitro Toxicology and Toxicity Testing Market Size by Application (2016-2021) (US$ Million)
Table 54. Latin America In-Vitro Toxicology and Toxicity Testing Market Size by Application (2022-2027) & (US$ Million)
Table 55. Latin America In-Vitro Toxicology and Toxicity Testing Market Size by Country (2016-2021) & (US$ Million)
Table 56. Latin America In-Vitro Toxicology and Toxicity Testing Market Size by Country (2022-2027) & (US$ Million)
Table 57. Middle East & Africa In-Vitro Toxicology and Toxicity Testing Market Size by Type (2016-2021) (US$ Million)
Table 58. Middle East & Africa In-Vitro Toxicology and Toxicity Testing Market Size by Type (2022-2027) & (US$ Million)
Table 59. Middle East & Africa In-Vitro Toxicology and Toxicity Testing Market Size by Application (2016-2021) (US$ Million)
Table 60. Middle East & Africa In-Vitro Toxicology and Toxicity Testing Market Size by Application (2022-2027) & (US$ Million)
Table 61. Middle East & Africa In-Vitro Toxicology and Toxicity Testing Market Size by Country (2016-2021) & (US$ Million)
Table 62. Middle East & Africa In-Vitro Toxicology and Toxicity Testing Market Size by Country (2022-2027) & (US$ Million)
Table 63. GE Healthcare Company Details
Table 64. GE Healthcare Business Overview
Table 65. GE Healthcare In-Vitro Toxicology and Toxicity Testing Product
Table 66. GE Healthcare Revenue in In-Vitro Toxicology and Toxicity Testing Business (2016-2021) & (US$ Million)
Table 67. GE Healthcare Recent Development
Table 68. Thermo Fisher Scientific Company Details
Table 69. Thermo Fisher Scientific Business Overview
Table 70. Thermo Fisher Scientific In-Vitro Toxicology and Toxicity Testing Product
Table 71. Thermo Fisher Scientific Revenue in In-Vitro Toxicology and Toxicity Testing Business (2016-2021) & (US$ Million)
Table 72. Thermo Fisher Scientific Recent Development
Table 73. Bio-Rad Laboratories Company Details
Table 74. Bio-Rad Laboratories Business Overview
Table 75. Bio-Rad Laboratories In-Vitro Toxicology and Toxicity Testing Product
Table 76. Bio-Rad Laboratories Revenue in In-Vitro Toxicology and Toxicity Testing Business (2016-2021) & (US$ Million)
Table 77. Bio-Rad Laboratories Recent Development
Table 78. Agilent Technologies Company Details
Table 79. Agilent Technologies Business Overview
Table 80. Agilent Technologies In-Vitro Toxicology and Toxicity Testing Product
Table 81. Agilent Technologies Revenue in In-Vitro Toxicology and Toxicity Testing Business (2016-2021) & (US$ Million)
Table 82. Agilent Technologies Recent Development
Table 83. Cyprotex Company Details
Table 84. Cyprotex Business Overview
Table 85. Cyprotex In-Vitro Toxicology and Toxicity Testing Product
Table 86. Cyprotex Revenue in In-Vitro Toxicology and Toxicity Testing Business (2016-2021) & (US$ Million)
Table 87. Cyprotex Recent Development
Table 88. Covance Company Details
Table 89. Covance Business Overview
Table 90. Covance In-Vitro Toxicology and Toxicity Testing Product
Table 91. Covance Revenue in In-Vitro Toxicology and Toxicity Testing Business (2016-2021) & (US$ Million)
Table 92. Covance Recent Development
Table 93. Bioreliance Company Details
Table 94. Bioreliance Business Overview
Table 95. Bioreliance In-Vitro Toxicology and Toxicity Testing Product
Table 96. Bioreliance Revenue in In-Vitro Toxicology and Toxicity Testing Business (2016-2021) & (US$ Million)
Table 97. Bioreliance Recent Development
Table 98. Catalent Company Details
Table 99. Catalent Business Overview
Table 100. Catalent Revenue in In-Vitro Toxicology and Toxicity Testing Business (2016-2021) & (US$ Million)
Table 101. Catalent Recent Development
Table 102. Charles River Laboratories International Company Details
Table 103. Charles River Laboratories International Business Overview
Table 104. Charles River Laboratories International In-Vitro Toxicology and Toxicity Testing Product
Table 105. Charles River Laboratories International Revenue in In-Vitro Toxicology and Toxicity Testing Business (2016-2021) & (US$ Million)
Table 106. Charles River Laboratories International Recent Development
Table 107. Alere Company Details
Table 108. Alere Business Overview
Table 109. Alere In-Vitro Toxicology and Toxicity Testing Product
Table 110. Alere Revenue in In-Vitro Toxicology and Toxicity Testing Business (2016-2021) & (US$ Million)
Table 111. Alere Recent Development
Table 112. Eurofins Scientific Company Details
Table 113. Eurofins Scientific Business Overview
Table 114. Eurofins Scientific In-Vitro Toxicology and Toxicity Testing Product
Table 115. Eurofins Scientific Revenue in In-Vitro Toxicology and Toxicity Testing Business (2016-2021) & (US$ Million)
Table 116. Eurofins Scientific Recent Development
Table 117. Life Technologies Corporation Company Details
Table 118. Life Technologies Corporation Business Overview
Table 119. Life Technologies Corporation In-Vitro Toxicology and Toxicity Testing Product
Table 120. Life Technologies Corporation Revenue in In-Vitro Toxicology and Toxicity Testing Business (2016-2021) & (US$ Million)
Table 121. Life Technologies Corporation Recent Development
Table 122. Quest Diagnostics Company Details
Table 123. Quest Diagnostics Business Overview
Table 124. Quest Diagnostics In-Vitro Toxicology and Toxicity Testing Product
Table 125. Quest Diagnostics Revenue in In-Vitro Toxicology and Toxicity Testing Business (2016-2021) & (US$ Million)
Table 126. Quest Diagnostics Recent Development
Table 127. Research Programs/Design for This Report
Table 128. Key Data Information from Secondary Sources
Table 129. Key Data Information from Primary Sources
List of Figures
Figure 1. Global In-Vitro Toxicology and Toxicity Testing Market Share by Type: 2020 VS 2027
Figure 2. Cell Culture Technology Features
Figure 3. High Throughput Technologies Features
Figure 4. Molecular Imaging Technologies Features
Figure 5. Omics Technologies Features
Figure 6. Global In-Vitro Toxicology and Toxicity Testing Market Share by Application: 2020 VS 2027
Figure 7. Pharmaceutical Industry Case Studies
Figure 8. Chemical Industry Case Studies
Figure 9. Food Industry Case Studies
Figure 10. Other Case Studies
Figure 11. In-Vitro Toxicology and Toxicity Testing Report Years Considered
Figure 12. Global In-Vitro Toxicology and Toxicity Testing Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 13. Global In-Vitro Toxicology and Toxicity Testing Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 14. Global In-Vitro Toxicology and Toxicity Testing Market Share by Regions: 2020 VS 2027
Figure 15. Global In-Vitro Toxicology and Toxicity Testing Market Share by Regions (2022-2027)
Figure 16. Global In-Vitro Toxicology and Toxicity Testing Market Share by Players in 2020
Figure 17. Global Top In-Vitro Toxicology and Toxicity Testing Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in In-Vitro Toxicology and Toxicity Testing as of 2020
Figure 18. The Top 10 and 5 Players Market Share by In-Vitro Toxicology and Toxicity Testing Revenue in 2020
Figure 19. Global In-Vitro Toxicology and Toxicity Testing Revenue Market Share by Type (2016-2021)
Figure 20. Global In-Vitro Toxicology and Toxicity Testing Revenue Market Share by Type (2022-2027)
Figure 21. North America In-Vitro Toxicology and Toxicity Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 22. North America In-Vitro Toxicology and Toxicity Testing Market Share by Type (2016-2027)
Figure 23. North America In-Vitro Toxicology and Toxicity Testing Market Share by Application (2016-2027)
Figure 24. North America In-Vitro Toxicology and Toxicity Testing Market Share by Country (2016-2027)
Figure 25. United States In-Vitro Toxicology and Toxicity Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Canada In-Vitro Toxicology and Toxicity Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe In-Vitro Toxicology and Toxicity Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. Europe In-Vitro Toxicology and Toxicity Testing Market Share by Type (2016-2027)
Figure 29. Europe In-Vitro Toxicology and Toxicity Testing Market Share by Application (2016-2027)
Figure 30. Europe In-Vitro Toxicology and Toxicity Testing Market Share by Country (2016-2027)
Figure 31. Germany In-Vitro Toxicology and Toxicity Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. France In-Vitro Toxicology and Toxicity Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. U.K. In-Vitro Toxicology and Toxicity Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Italy In-Vitro Toxicology and Toxicity Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Russia In-Vitro Toxicology and Toxicity Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Nordic In-Vitro Toxicology and Toxicity Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific In-Vitro Toxicology and Toxicity Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Asia-Pacific In-Vitro Toxicology and Toxicity Testing Market Share by Type (2016-2027)
Figure 39. Asia-Pacific In-Vitro Toxicology and Toxicity Testing Market Share by Application (2016-2027)
Figure 40. Asia-Pacific In-Vitro Toxicology and Toxicity Testing Market Share by Region (2016-2027)
Figure 41. China In-Vitro Toxicology and Toxicity Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Japan In-Vitro Toxicology and Toxicity Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. South Korea In-Vitro Toxicology and Toxicity Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Southeast Asia In-Vitro Toxicology and Toxicity Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. India In-Vitro Toxicology and Toxicity Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Australia In-Vitro Toxicology and Toxicity Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America In-Vitro Toxicology and Toxicity Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Latin America In-Vitro Toxicology and Toxicity Testing Market Share by Type (2016-2027)
Figure 49. Latin America In-Vitro Toxicology and Toxicity Testing Market Share by Application (2016-2027)
Figure 50. Latin America In-Vitro Toxicology and Toxicity Testing Market Share by Country (2016-2027)
Figure 51. Mexico In-Vitro Toxicology and Toxicity Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Brazil In-Vitro Toxicology and Toxicity Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa In-Vitro Toxicology and Toxicity Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Middle East & Africa In-Vitro Toxicology and Toxicity Testing Market Share by Type (2016-2027)
Figure 55. Middle East & Africa In-Vitro Toxicology and Toxicity Testing Market Share by Application (2016-2027)
Figure 56. Middle East & Africa In-Vitro Toxicology and Toxicity Testing Market Share by Country (2016-2027)
Figure 57. Turkey In-Vitro Toxicology and Toxicity Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. Saudi Arabia In-Vitro Toxicology and Toxicity Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. UAE In-Vitro Toxicology and Toxicity Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 60. GE Healthcare Revenue Growth Rate in In-Vitro Toxicology and Toxicity Testing Business (2016-2021)
Figure 61. Thermo Fisher Scientific Revenue Growth Rate in In-Vitro Toxicology and Toxicity Testing Business (2016-2021)
Figure 62. Bio-Rad Laboratories Revenue Growth Rate in In-Vitro Toxicology and Toxicity Testing Business (2016-2021)
Figure 63. Agilent Technologies Revenue Growth Rate in In-Vitro Toxicology and Toxicity Testing Business (2016-2021)
Figure 64. Cyprotex Revenue Growth Rate in In-Vitro Toxicology and Toxicity Testing Business (2016-2021)
Figure 65. Covance Revenue Growth Rate in In-Vitro Toxicology and Toxicity Testing Business (2016-2021)
Figure 66. Bioreliance Revenue Growth Rate in In-Vitro Toxicology and Toxicity Testing Business (2016-2021)
Figure 67. Catalent Revenue Growth Rate in In-Vitro Toxicology and Toxicity Testing Business (2016-2021)
Figure 68. Charles River Laboratories International Revenue Growth Rate in In-Vitro Toxicology and Toxicity Testing Business (2016-2021)
Figure 69. Alere Revenue Growth Rate in In-Vitro Toxicology and Toxicity Testing Business (2016-2021)
Figure 70. Eurofins Scientific Revenue Growth Rate in In-Vitro Toxicology and Toxicity Testing Business (2016-2021)
Figure 71. Life Technologies Corporation Revenue Growth Rate in In-Vitro Toxicology and Toxicity Testing Business (2016-2021)
Figure 72. Quest Diagnostics Revenue Growth Rate in In-Vitro Toxicology and Toxicity Testing Business (2016-2021)
Figure 73. Bottom-up and Top-down Approaches for This Report
Figure 74. Data Triangulation
Figure 75. Key Executives Interviewed
世界のIn-Vitro毒性/毒性試験市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global In-Vitro Toxicology/ Toxicity Testing Market The global In-Vitro Toxicology/ Toxicity Testing market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026. With industry-standard accuracy in analysis and…- 世界の医療用In-Vitro毒性試験市場規模・現状・予測（2021年-2027年） The main purpose is to guide the clinical rational use of drugs, reduce adverse drug reactions and reduce the failure of new drug development due to drug toxicity. Market Analysis and Insights: Global Medical In-Vitro Toxicology Testing Market The global Medical In-Vitro Toxicology Testing market si…
- 世界の医療用In-Vitro毒性試験市場規模・現状・予測（2021年-2027年） The main purpose is to guide the clinical rational use of drugs, reduce adverse drug reactions and reduce the failure of new drug development due to drug toxicity. Market Analysis and Insights: Global Medical In-Vitro Toxicology Testing Market The global Medical In-Vitro Toxicology Testing market si…
- 世界のIn-vitro毒性試験市場規模・現状・予測（2021年-2027年） In-vitro toxicity testing is the scientific analysis of the effects of toxic chemical substances on cultured bacteria or mammalian cells. Significant progress in toxicology science is one of the key trends escalating market growth. Besides this, socio-ethical concerns pertaining to animal tests and …
- 世界のIn Vitro毒性検査市場規模・現状・予測（2021年-2027年） In vitro toxicity testing is the scientific analysis of the effects of toxic chemical substances on cultured bacteria or mammalian cells. In vitro testing methods are employed primarily to identify potentially hazardous chemicals and/or to confirm the lack of certain toxic properties in the early st…